ASX Announcements 2024 6 Sep 2024BIT225-012 Phase 2 COVID-19 Clinical Trial 30 Aug 2024Corporate Governance Statement 2024 30 Aug 2024Appendix 4G 30 Aug 2024Year End Accounts and Preliminary Final Report 31 Jul 2024Quarterly Report 30 June 2024 31 Jul 2024Report on Activities for the Quarter Ended 30 June 2024 11 Jul 2024Shareholder Update 25 Jun 2024Biotron Clinical Trial Results Webinar 19 Jun 2024BIT225-011 Phase 2 HIV Exploratory Efficacy Trial Meets Primary Objectives 24 May 2024Change of Registry Address Notification 26 Apr 2024Quarterly Report 31 March 2024 26 Apr 2024Report on Activities for the Quarter Ended 31 March 2024 5 Apr 2024Positive Outcomes in BIT225 Phase 2 Clinical Trial in HIV (BIT225-010) 27 Feb 2024Half-year Report 31 December 2023 8 Feb 2024R&D Tax Incentive 30 Jan 2024Report on Activities for the Quarter Ended 31 December 2023 30 Jan 2024Quarterly Report 31 December 2023 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 >>
